IQVIA, which is a leading global provider when it comes to clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries, on December 02, 2025, went on to announce a strategic collaboration with Amazon Web Services – AWS naming AWS as the Preferred Agentic Cloud Provider for IQVIA.
The partnership, revealed at the AWS re:Invent, is indeed quite a prominent step in terms of the digital transformation of healthcare as well as the life sciences spectrum, which aims to revolutionize clinical trial automation and medical affairs along with analytics by way of an innovative agentic AI platform.
As per the agreement, IQVIA is going to roll out its AI platform on the AWS network in order to elevate scalable, safe as well as intelligent automation throughout the clinical trial execution, medical affairs as well as healthcare analytics. This partnership is designed especially to enhance the clinical trial automation and, at the same time, speed up the trial processes. Additionally, IQVIA as well as AWS are going to explore certain novel opportunities within life science analytics in order to drive the next generation of data-driven insights along with solutions.
As 90% of the largest pharmaceutical companies in the world depend on both IQVIA and AWS in order to power their digital transformation as well as analytics, the companies are indeed committed so as to democratizing AI for life sciences, speeding drug innovation, and also helping with faster delivery related to life-saving treatments for patients across the world.
As per the SVP for Architecture and Standards at IQVIA, Lucas Glass, they are indeed excited to move forward with AWS as being the Preferred Agentic Cloud Provider of IQVIA. Their AI platform looks forward to empowering the life sciences organizations to go ahead and innovate faster and also roll out treatments to patients in a more efficient way. Due to agentic AI, they are going to unlock new possibilities for their clients and also the industry at large.
Director of Global Healthcare and Life Sciences with Amazon Web Services, Allyson Fryhoff, said that they are indeed thrilled to go ahead and support the Agentic AI platform from IOQVIA with a comprehensive breadth of cloud capabilities by AWS. He added that together they aim to help the life sciences sector leverage the power of AI in order to support the ongoing innovation within healthcare and attain outcomes that at one point were perceived to be impossible.
This kind of strategic collaboration goes on to showcase a new era when it comes to agentic AI in life sciences, where the intelligent cloud-powered solutions enable greater efficiency, speed up innovation, and also upgrade the patient outcomes.
